Prolintane

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];

Aditya Govindavarjhulla, M.B.B.S. [2]

Prolintane

Clinical data
ATC code	N06BX14 (WHO)
Identifiers
IUPAC name 1-(1-phenylpentan-2-yl)pyrrolidine
CAS Number	493-92-5
PubChem CID	14592
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}
Chemical and physical data
Formula	C15H23N
Molar mass	217.35 g/mol

Overview

Prolintane (Promotil, Katovit) is a psychostimulant/nootropic.

Prolintane is a stimulant closely related in structure to other drugs such as pyrovalerone and presumably has a similar mechanism of action, by inhibiting the reuptake of dopamine and other monoamine neurotransmitters. Prolintane is a mild stimulant with a good safety profile and relatively low incidence of cardiovascular problems or other side effects such as anorexia and insomnia, although these side effects may still occur at higher doses. However the good safety profile of this drug at low doses makes it suitable for use in elderly people to increase motivation and counteract the effects of senile dementia and age-related cognitive decline. It is mainly used in European countries.

Side effects

• Loss of appetite

• Weight loss

• Headache

• Dry mouth

• Skin rash

• Sweating

• Ringing in the ears

• Shakiness and nervousness

• Stomach pain

• Agitation

• Constipation

• Anxiety Dizziness
• Trouble sleeping

• Muscle pain

• Nausea

• Tachycardia

• Sore throat

• Frequent urination

Withdrawal

• Aggression

• Anxiety

• Blurred vision

• Brain zaps

• Constipation

• Crying spells

• Depersonalization

• Diarrhea

• Dizziness

• Fatigue

• Flatulence

• Flu-like symptoms

• Hallucinations

• Hostility

• Indigestion

• Irritability

• Impaired speech

• Insomnia

• Migraine headache

• Paranoia

• Akathasia

• Stomach cramps

• Tremors

• Tinnitus

• Visual hallucinations / illusions

• Worsened depression

Template:Pharmacology-stub Template:Stimulants Template:Psychostimulants, agents used for ADHD and nootropics